Literature DB >> 9951854

Characteristics and treatment of mucin-producing tumor of the pancreas.

W Kimura1, M Makuuchi, A Kuroda.   

Abstract

BACKGROUND/AIMS: There has been no thorough clinicopathological analysis of a large number of cases with mucin-producing tumor of the pancreas. The aim of this study was to investigate the clinicopathological features of and therapeutic strategy for this ailment.
METHODOLOGY: Two hundred and fifty-nine cases of mucin-producing tumor of the pancreas were analyzed clinicopathologically.
RESULTS: Mucin-producing tumor of the pancreas was found in 177 males and 82 females (M:F=2.2:1). The mean age was 65.5 years. Jaundice, diabetes mellitus and a past history of pancreatitis were found in 15-19% of the cases. The tumor was most frequently (62%) found in the head of the pancreas. Pathologically, hyperplasia or adenoma was found in 58 cases, and adenocarcinoma in 160 cases. Five-year survival rate by the Kaplan-Meier method was 82.6% in all of the cases, and the post-operative survival curve was much better in cases with this type of carcinoma than in cases with ordinary pancreatic duct cell carcinoma (5-year survival rate: 17.3%). Organ-function preserving procedures, such as duodenum preserving subtotal resection of the head of the pancreas or spleen preserving distal pancreatectomy, might be recommended for this disease without infiltration.
CONCLUSIONS: Mucin-producing tumor has unique clinicopathological characteristics, such as the dilated main pancreatic duct or branches, dilatation of the orifice of the papilla of Vater, or a good prognosis. Organ-function preserving procedures should be recommended in some cases with this ailment.

Entities:  

Mesh:

Year:  1998        PMID: 9951854

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

Review 1.  [Duodenum-preserving total pancreatic head resection : an organ-sparing operation technique for cystic neoplasms and non-invasive malignant tumors].

Authors:  H G Beger; M Siech; B Poch
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

2.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Authors:  C A Iacobuzio-Donahue; D S Klimstra; N V Adsay; R E Wilentz; P Argani; T A Sohn; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 3.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

4.  Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.

Authors:  Dimitrios Karakaxas; Maria Gazouli; Ahmet Coker; Christos Agalianos; Ioannis S Papanikolaou; Pavlos Patapis; Theodoros Liakakos; Christos Dervenis
Journal:  Med Oncol       Date:  2014-09-12       Impact factor: 3.064

Review 5.  Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.

Authors:  Ersin Gürkan Dumlu; Derya Karakoç; Arif Özdemir
Journal:  Int Surg       Date:  2015-06

Review 6.  Management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masanori Sugiyama; Yutaka Suzuki; Nobutsugu Abe; Toshiyuki Mori; Yutaka Atomi
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

7.  Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.

Authors:  Ma Jinfeng; Wataru Kimura; Fumiaki Sakurai; Toshiyuki Moriya; Akiko Takeshita; Ichiro Hirai
Journal:  Int J Gastrointest Cancer       Date:  2002

8.  Prognostic significance of the labeling of Adnab-9 in pancreatic intraductal papillary mucinous neoplasms.

Authors:  M Tobi; J Hatfield; V Adsay; K Galagan; R Kozarek; M Inagaki; S Kasai; Y Tokusashi; T Obara; R H Hruban; J Lough; A N Barkun; M Jabbari; R Sheikh; B Ruebner; M J Lawson; E Ben-Josef; S Fligiel
Journal:  Int J Pancreatol       Date:  2001
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.